Search Results

GPCRs in Oncology and Immunology LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine , impairs growth of patient-derived xenografts of colorectal carcinoma in mice Published date February 1, 2023 Abstract " LP2 is a 4, 7 D, L lanthionine-stabilized analog of angiotensin-(1-7), with an N-terminal D-lysine, resistant to breakdown by peptidases. injected dose as low as 0.2 µg/kg/day inhibited patient-derived xenografts of colorectal carcinoma in mice

These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific

discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D

In particular, she is looking at L- and D-lactate-activated HCAR1 signaling.

His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs

Yamina Berchiche on the web D r.

schedule A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice Date & Time Friday, November 3rd / 1:55 PM About Khaled Abdelrahman Dr.

this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&D

I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart

I received my PhD in Biology at Arizona State University, where I worked in the lab of Miles Orchinik

I have 10 years of experience in the development and management of R&D projects and teams in the field

of a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D

Leipzig, Germany 2 Institute of Medical Physics and Biophysics, Leipzig University, Härtelstr. 16-18, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of General Biochemistry, Leipzig University, Johannisallee 30, D- Rudolf-Schönheimer-Institute of Biochemistry, Division of Molecular Biochemis-try, Leipzig University, Johannisallee 30, D-

He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder

Authors R Mishra, S K Biswas, S Nandi, S Mahajan, K G Sai Balaji, V Gairola, D Poloju, S Gulzar, K P

Authors Nick D Bergkamp , Jeffrey R van Senten , Hendrik J Brink , Maarten P Bebelman , Jelle van den

, Eduardo Rodríguez-Arbolí , Megan Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D

G-protein-coupled receptor class C group 5 member D (GPRC5D), an orphan GPCR predominantly expressed

Yanamoto , Kotaro Tanimoto , Hitoshi Hashimoto , Yukio Ago Tags Cell cycle , Cell proliferation , Cyclin D

Authors Adriana Stuardo-Parada , Rodrigo López-Muñoz , Franz Villarroel-Espindola , Carlos D Figueroa

Authors Julia Tutzauer , D Stephen Serafin , Tobias Schmidt , Björn Olde , Kathleen M Caron , L M Fredrik

Ceddia 1, *, Zack Zurawski 2,3,*, Analisa Thompson Gray 2, Feyisayo Adegboye 2, Ainsley McDonald-Boyer

Authors Charles H Williams , Leif R Neitzel , Jessica Cornell , Samantha Rea , Ian Mills , Maya S Silver , Jovanni D Ahmad , Konstantin G Birukov , Anna Birukova , Henry Brem , Betty Tyler , Eli E Bar , Charles

Oncology and Immunology A GPCR checkpoint drives CD8+ T cell dysfunction and immunotherapy failure in mice

Genetic Deletion of Atypical VGLUT3 Rescues Huntington’s Disease Phenotype and Neurodegeneration in zQ175 Mice

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in

My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed

gpcrs-in-cardiology-endocrinology-and-taste/latrophilin-2-deletion-in-cardiomyocyte-disrupts-cell-junction%2C-leading-to-d-cmp